| 摘要 |
Medical implants are provided which release an anthracycline, fluoropyrimidine, folic acid antagonist, podophylotoxin, camptothecin, hydroxyurea, and/or platinum complex, thereby inhibiting or reducing the incidence of infection associated with the implant. |
| 申请人 |
ANGIOTECH PHARMACEUTICALS, INC.;HUNTER, WILLIAM, L.;GRAVETT, DAVID, M.;TOLEIKIS, PHILIP, M.;LIGGINS, RICHARD, T.;LOSS, TROY, A. E. |
发明人 |
HUNTER, WILLIAM, L.;GRAVETT, DAVID, M.;TOLEIKIS, PHILIP, M.;LIGGINS, RICHARD, T.;LOSS, TROY, A. E. |
